TNGX - Wall Street Estimates - Tango Therapeutics, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 1.995

-3.62 %

$ 216 M

Market Cap

-1.68

P/E

Price Target Average

635.17%

Revenue Forecast Estimate

--1.71%

EBIT Estimate

34.55%

Net Income Estimate

--8.65%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Tango Therapeutics, Inc.

Wall Street analysts predict an average 1-year price target for TNGX of $14.7 , with forecasts ranging from a low of $13 to a high of $18 .

TNGX Lowest Price Target Wall Street Target

13 USD 551.63%

TNGX Average Price Target Wall Street Target

14.7 USD 635.17%

TNGX Highest Price Target Wall Street Target

18 USD 802.26%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free